Latest Earnings Results: Q2 '26
Estimated EPS
$1.93
Reported EPS
$2.05
Surprise
+6.35%
Estimated Rev
$1.63B
Reported Rev
$1.71B
Surprise
+4.3%
$ONC Q2 '26 Earnings Results & Recap BeOne Medicines Ltd. raised its 2026 total revenue guidance to $6.6 billion to $6.8 billion, with GAAP operating income of $1.0 billion to $1.1 billion and non-GAAP operating income of $1.7 billion to $1.8 billion.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.90 | -- | -- | N/A |
Q2 '26 | $1.93 | $2.05 | 6.35% | BEAT |
Q1 '26 | $1.73 | $1.96 | 13.07% | BEAT |
Q4 '25 | $1.21 | $0.60 | -50.28% | MISSED |
Q3 '25 | $0.85 | $1.09 | 28.15% | BEAT |